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Abstract
Background: A recent survey has shown that data management in clinical trials performed by academic trial units
still faces many difficulties (e.g. heterogeneity of software products, deficits in quality management, limited human
and financial resources and the complexity of running a local computer centre). Unfortunately, no specific, practical
and open standard for both GCP-compliant data management and the underlying IT-infrastructure is available to
improve the situation. For that reason the “Working Group on Data Centres” of the European Clinical Research
Infrastructures Network (ECRIN) has developed a standard specifying the requirements for high quality GCP-
compliant data management in multinational clinical trials.
Methods: International, European and national regulations and guidelines relevant to GCP, data security and IT
infrastructures, as well as ECRIN documents produced previously, were evaluated to provide a starting point for the
development of standard requirements. The requirements were produced by expert consensus of the ECRIN
Working group on Data Centres, using a structured and standardised process. The requirements were divided into
two main parts: an IT part covering standards for the underlying IT infrastructure and computer systems in general,
and a Data Management (DM) part covering requirements for data management applications in clinical trials.
Results: The standard developed includes 115 IT requirements, split into 15 separate sections, 107 DM
requirements (in 12 sections) and 13 other requirements (2 sections). Sections IT01 to IT05 deal with the basic IT
infrastructure while IT06 and IT07 cover validation and local software development. IT08 to IT015 concern the
aspects of IT systems that directly support clinical trial management. Sections DM01 to DM03 cover the
implementation of a specific clinical data management application, i.e. for a specific trial, whilst DM04 to DM12
address the data management of trials across the unit. Section IN01 is dedicated to international aspects and ST01
to the competence of a trials unit’s staff.
Conclusions: The standard is intended to provide an open and widely used set of requirements for GCP-compliant
data management, particularly in academic trial units. It is the intention that ECRIN will use these requirements as
the basis for the certification of ECRIN data centres.
Background
Clinical Data Management Systems (CDMS) are used
more and more to handle the increasing amount of data
that must be collected, processed and analysed in clinical
research, whether that data is initially captured remotely
and directly from clinical sites using Remote Data
Capture (RDC), or using more traditional paper based
methods [1]. The development and maintenance of an
appropriate data management environment is a tough
challenge for academic clinical trials units. A recent sur-
vey showed several problems with data management sys-
tems in clinical trials conducted at academic centres [2]:
a) There is considerable heterogeneity in the use of
different software products for data management, and
often proprietary solutions are in place rather than open
source or industry supported commercial products.
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ment, including in computer system validation.
c) Most centres are constrained by limited human and
financial resources in providing adequate levels of data
management.
d) The complexities of running a local IT/data man-
agement centre, especially for international clinical trials,
are underestimated.
e) There exists no widely recognised, specific, practic-
able and open standard for GCP-compliant data man-
agement and the accompanying IT infrastructure.
To expand upon the last point: GCP requirements on
data management are mostly unspecific at the technical
level [3]. EU Directive 2001/20/EC [4], EU Directive
2005/28/EC [5] and Annex 11 [6] define GCP compli-
ance for clinical trials but specify only a few technical
requirements for data management (e.g. necessity for
data privacy, security system, system descriptions). The
FDA Guidance for Computerized System Used in Clini-
cal Trials [7] or 21 CFR Part 11 [8] covering electronic
records and electronic signatures are legally binding in
the US but have less relevance for the EU. Similarly,
specific regulations exist in many EU countries and sev-
eral national guidance documents for IT are available
(e.g. UK, Germany, Denmark) but with limited or no
relevance for other countries [9-12].
For computer system validation purposes a number of
additional guidelines are in use for specific aspects of
data management, like the PIC/S Guide [13], which
defines requirements from the inspectors’ point of view
and the GAMP
® guide [14] defining best practices for
system validation. On the other hand, ISO standards
cover only the general level of IT infrastructure aspects
(e.g. ISO 27001, security management system [15]).
The Good Clinical Data Management Practices (e.g.
v e r s i o n4 )[ 1 6 ] ,p r o p o s e da sa ni n d u s t r ys t a n d a r df o r
clinical data management, consists of best business prac-
tice and acceptable regulatory standards but is mostly
intended for GCP compliance training. Members of the
Society of Clinical Data Management (SCDM) can
download the guide, non-members may purchase the
copyright protected document.
In summary, there is no standard for GCP-compliant
data management and the underlying IT infrastructure
available, which is both generally applicable and practi-
cal, as well as being open and available free of charge.
The European Clinical Research Infrastructures Net-
work (ECRIN) [17] is an EU-funded ESFRI- (European
Strategy Forum on Research Infrastructures) roadmap
project in biological and medical sciences, designed to
support clinical research in Europe through providing
consulting and other services to investigators and spon-
sors for multinational clinical trials. ECRIN provides a
not-for-profit platform for the support of pan-European
clinical research projects. It does this by connecting
national networks of clinical research centres (CRCs)
and clinical trial units (CTUs), working across all disease
areas.
To support clinical trials ECRIN intends to provide a
combined DM- and IT-framework using data manage-
ment systems located in dedicated ECRIN data centres.
As part of realising this aim, ECRIN recognised the
need for a set of clear standards for data management
and the associated IT infrastructure - to guarantee
GCP-compliant, efficient, high quality and secure opera-
tions in those data centres. Within ECRIN a certification
procedure will be generated for data centres based upon
the standards presented in this publication.
Methods
Overview
Standard requirements were formulated by expert con-
sensus of the ECRIN Working Group on Data Centres.
The consensus was developed by a structured and stan-
dardized process, coordinated by the chairman of the
group and two subgroup leaders. The approach con-
sisted of the following features:
a) a large panel of 25 DM experts with a variety of
national origins (11 countries), high expertise and pro-
fessional background (see list of Working Group
members).
b) open discussion by experts (written and orally) with
feedback of all responses to all experts.
c) iterations with several rounds of consensus building
based on strict versioning of documents with tracking of
changes.
d) highly structured representation of requirements as
a standardised list of statements.
In the section “discussion” this methodological
approach is compared to a more formal consensus
development method (e.g. Delphi method, nominal
group technique).
Considered regulations and guidelines
In developing the ECRIN standard, compliance with
ICH GCP [3] was seen as the central requirement. The
European directives and guidelines dealing with clinical
research all refer to this document (Figure 1), indicat-
ing the central importance of GCP for data manage-
ment in clinical trials. ICH GCP section 5 [3] describes
some requirements for the use of electronic trial data
and computer systems, e.g. the sponsors operating
such computer systems must validate their systems,
maintain SOPs for their use, ensure an audit trail for
each data change and provide for data security. In
addition, further relevant documents were consulted.
In summary, the following documents were taken into
consideration.
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- ISO 27001 Information Security Management -
Specification [15]
European
- EU Directive for the implementation of GCP 2001/
20/EC [4],
- EU Directive 2005/28/EC [5],
- EU Directive 95/46/EC [18],
- Computerized Systems, EudraLex - Volume 4,
Annex 11 [6],
- EMEA Reflection paper on expectations for elec-
tronic source documents used in clinical trials [19],
- ECRIN deliverable D10: GCP-compliant data man-
agement in multinational trials [20],
Other international documents
- Good practice for computerised systems in regulated
GXP environments, PIC/S Inspectors Guide [13],
- Good Clinical Data Management Practice, Version
4 of the Society for Clinical Data Management,
October 2005 [16],
- Good Automated Manufacturing Practice
(GAMP
R) Version 5 of the International Society for
Pharmaceutical Egineering (ISPE) [14].
National
- Implementation of Good Clinical Practice Software
(University of Southern Denmark) [9],
- German Coordinating Centres for Clinical Trials
Networks Policy Document [10],
- Data and Information Management Systems Pro-
ject (DIMS) - System Standards of UKCRC/NIHR
(UK) [12],
- IT-Grundschutz Methodology of the Bundesamt
für Sicherheit in der Informationstechnik (BSI) [11],
and
Figure 1 Standards and guidelines related to GCP. International and European regulations and guidelines that are relevant for GCP-compliant
computer systems and data management are displayed as small boxes. Arrows connecting these documents indicate important references from
one document to another (e.g. the arrow from EU-Dir 2005/28 to EU-Dir 95/46 means that EU-Dir 2005/28 refers to EU-Dir 95/46). The
correspondence of ICH E6 GCP and European CPMP ICH/135/95 is indicated by a bold arrow.
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Used in Clinical Trials [7] and 21 CFR Part 11 [8].
These documents stimulated discussion and ideas in
the Working Group, and sometimes directly suggested a
requirement statement. Thus, for example, the require-
ments of Annex 11 and 21 CFR Part 11 for a clinical
data audit trail and the insistence of ISO 27001 that a
security management system must be in place could
both be included in the requirements list. We found,
however, that statements were often too general when it
came to the need of specific clinical trial processes and
structures. In general, therefore, we have concentrated
on defining standard requirements that, whilst certainly
in line with the documents listed above, and with the
principles of GCP in particular, reflect the special needs
of data centres in clinical trials units.
Differences in national regulations of data manage-
ment for clinical trials were also discussed in the Work-
ing Group; for example, specific regulatory requirements
and standards are necessary for IT support of clinical
trials in Denmark, UK, Germany, and other countries.
In Denmark, for example, special standards have had to
be applied for the implementation of the infrastructure
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Figure 2 Relationships between the IT and the DM sections in the ECRIN standard. The different sections in the IT part and the DM part of
the ECRIN standard. Relationships are indicated by arrows (CDMS = clinical data management system, IT = information technology, DM = data
management, DBMS = data base management system).
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the application of certain ISO-standards necessary. To
avoid the generation of an overly complex document,
the Working Group decided to aim for an Europe wide
document, not considering specific national standards
but phrasing the requirements in such terms that most
national specifications could be covered. Thus the
requirements were kept as generic as possible but also
specific enough to be useful for the conduct of a data
centre to support clinical research.
Process of expert consensus
Based on requirements extracted from the documents
listed above, an already existing ECRIN document on
GCP-compliant data management in multinational trials
[20], and especially with help from the groundwork of
the UK DIMS Project Team [12], a requirements catalo-
gue for GCP-compliant computer system based data
management was developed based on expert consensus
and formulated as a standard.
To structure the consensus process, the ECRIN
Working Group was divided in two subgroups: an
Information Technology (IT) subgroup and an Data
Management (DM) subgroup, each group working on
different requirements. This divison was useful in distin-
guishing general IT aspects from trial related aspects of
data management, though interactions between these
two areas were also taken into consideration.
A computer system used for clinical trials cannot be
regarded as an isolated application. It must be seen as
part of the IT infrastructure of the trial centre using it.
The IT subgroup therefore looked at various aspects of
that infrastructure as well as systems specifically
designed to support clinical trials. Similarly, the DM
group examined not just trial specific components of
data management systems (in particular the clinical
data management application) but also the general
aspects of data management systems that are used by
all trials.
To reach expert consensus, the following procedure
was followed strictly in the process of development of
the requirements:
- provision of requirements as a list of statements,
each statement with an ID number and a precise
description, and categorised as either a ‘minimal’
requirement or ‘best practice’
- provision of a draft version of the requirements to
the WP-members
- collection of written feedback
- telephone conference or face-to-face meeting with
point by point discussion of individual requirements
- provision of an updated version with a track of the
changes to all WP members
This cycle was repeated with several iterations (7 tele-
phone conferences). In addition, the group conducted
three face-to-face-meetings, one with participation of
international accreditation experts (14 September 2009)
and a final full day meeting (March 2010) examining all
the remaining contentious issues in detail, and in parti-
cular the relationships between the IT and DM stan-
dards, as well as the final format of the document.
Results
The requirements are divided into an IT and a DM part.
In summary, the ECRIN standard covers 115 IT require-
ments, 107 DM requirements and 13 other require-
ments. Within each part, there are sections dealing with
specific topics, such as “Logical Security and Manage-
ment (IT03)” or “Query Management (DM08)”. Sections
are marked by “IT” or “DM” and a number (e.g. DM03).
In summary, there are 15 sections related to IT, 12 to
DM and two dealing with other aspects. The sections
are presented in Figure 2. The first group of sections
(IT01 through IT05) deals with the basic IT infrastruc-
ture of a data centre, while IT06 and IT07 cover two
critical aspects of local IT culture (validation and local
software development). The next groups of require-
ments are more focused on functions specific to data
centres; functions generally used (and assessed) within
the context of specific trials. Thus, IT08 to IT15 are
concerned with IT systems that directly support clinical
trial data management. DM01 to DM03 cover the
implementation of a specific clinical data management
application. DM04 to DM12 address aspects of data
management across trials, for example data entry, qual-
ity checks and coding.
For each section the requirements are organised as a
list of individual requirements with three columns (iden-
tification number (ID), e.g. IT03.07), category (minimal
or best practice) and textual description). The full set of
requirements is available as an attachment to this docu-
ment (additional file 1).
Though the standard is organised as sections with lists
of requirements, the relationships that exist between the
sections of the IT and DM parts are rather complex. The
relationships are presented in Figure 2. In some cases,
obvious links between the IT and the DM sections exists
(Figure 2). IT09-DM04, IT14-DM11 and IT15-DM12 are
all corresponding pairs of sections, actually dealing with
t h es a m et o p i ci ne a c hc a s eb u tf r o ma nI T -a n dD M -
perspective respectively. They should therefore be con-
sidered together when examining the list. Similarly, IT08
includes some IT specific standards to be expected in
clinical database systems, to complement the data man-
agement standards of DM01, 02 and 03.
Finally, there are two sections (IN01 and ST01) that
deal with more general aspects of the data centre’sw o r k
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subgroups. Some of these additional requirements are
focused on international aspects (e.g. user support,
translation of eCRFs) and others on staff competence
(e.g. training, support) but both are necessary to cover
support of European wide clinical trials.
Because the standard is set out as sections with lists of
requirements with only short descriptions, it can be
used easily as a checklist, e.g. for self assessment.
Discussion
Standards and requirements for GCP-compliant data
management
In establishing a consensus for GCP-compliant data man-
agement, the underlying IT infrastructure and the relevant
indicators of good GCP practice have been the driving
force for the ECRIN Working Group on Data Centres.
The development of a standard was initiated by a per-
ceived lack of clarity in this area and the existing heteroge-
nity within academic clinical trial data centres [2]. The aim
of this approach and the standard requirements developed
is to bring ECRIN and other data centres to the same level
of quality and standardisation and to make them evolve
towards a common quality level. But there is no claim that
the ECRIN standard represents the definitive standard for
all clinical trial centres. The validity and practicality of the
ECRIN standard will need evaluation by clinical trial units
data centres themselves. The scope of the standard is lim-
ited to the structure, function and use of computer sys-
tems for clinical trials and the value, accuracy and
integrity of the data generated and does not cover other
aspects of clinical trials. Therefore, the ECRIN standard
should not be perceived or managed in isolation from
other quality management systems in clinical trial units.
There is no attempt to justify each requirement in any
detail, though some are commented more specifically.
This paper does not consider the possible consequences
of non-compliance in any detail and it does not specify
any risk of non-compliance. That is seen as an issue for
those who might audit a data management centre.
Clinical data management centres vary considerably in
their size, in the available resources and in the extent of
quality management [2]; and so some centres are much
more likely to have reached certain levels of GCP com-
pliance than others. One important discussion point in
the Working Group was that the standard has to reflect
what the majority of ECRIN partners or other trial units
providing data management services can realistically
achieve with their available resources. This is a point of
concern for many academic research centres.
For instance, system validation plays an important
part in ensuring GCP-compliance of a computer sys-
tem but can be problematic. Academic units do not, in
general, have the resources available in the pharma
industry to conduct or outsource a ‘full’ validation for
every system component, including the vendor audit,
and to maintain complete change management. In
addition, there is no simple way to know how much
system validation is necessary or sufficient [21] and the
extent and depth of validation required may depend on
the interpretation of a particular auditor and whether a
commercial software or an inhouse developed software
is used. We do acknowledge, however, that system
validation probably needs to be improved in many
ECRIN centres [2].
Accordingly, the ECRIN standard does not stipulate
the best possible IT infrastructure, but instead tries to
define minimum requirements and best practice. In this
way it allows flexibility wherein centres can develop
their resources and improve their operations. Best prac-
tices are often worthy of implementation, and may over
time become more attainable for all centres. In this way,
standards, if they are sufficiently supported and
explained, may not only become generally accepted but
can also be used as a tool for improvement. At this time
it would be impractical, for instance, to insist on the use
of specific data standards (e.g. the use of CDISC ODM
for metadata) despite their many advantages, especially
for international trials [22 ] .N o n e t h e l e s s ,a nu p d a t e d
standard may in future include addtional requirements
for metadata export using ODM [23] and centres would
be expected to comply with it.
Academic clinical trial units are often part of their
corresponding university IT infrastructure. In some
cases a part or all of the functionality covered by the
standard will not be the direct responsibility of the cen-
tre or the trials unit itself, falling instead within the
remit of the computer centre of the university or even
an outside service provider. For example, IT infrastruc-
t u r es e r v i c e sm a yb ep r o v i d e db yt h ep a r e n to r g a n i s a -
tion, or a commercial host, or another collaborating
trials unit. In such cases, the data centre using the
ECRIN requirements should have formal written agree-
ments, e.g. in the form of contracts or service level
agreements (SLAs), that ensure that the relevant
requirements of the standard will be met by the organi-
sation(s) that provides them.
This attempt to introduce a new standard into the
field of computer systems in clinical trials must deal
with two related questions: a) What is the justification
for a new requirements standard for trials units? and b)
how does this new standard fit in with existing require-
ments for IT systems, validation, data management etc?
The prime justification for the standard stems from
the recognition that a deficit in clinical research should
r e s u l ti nt h ee s t a b l i s h m e n to fat o o lt oo v e r c o m ea n d
improve the situation. Clinical research is dependent
upon high quality, reliable and GCP-compliant tools,
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However and as decribed in “background”,n of r e e l y
available and sufficiently detailed standard currently
exists to evaluate such systems.
Similar difficulties have arisen with several other
recent initiatives, e.g. the evaluation of breast cancer
centres (EUSOMA) [24] and phase I trial centres
(MHRA) [25], or the accreditation of centres for first-in-
man studies (JACIE) [26]. In these cases too, require-
ments were first developed to have a standard available
to judge the quality of a structure, process or service.
The IT/DM requirements developed by ECRIN follow
the same path and offer a quality standard for all inter-
ested academic clinical centres that conduct electronic
data management in clinical trials to support quality
assessment within these centres. This standard is, how-
ever, not restricted to academic centres; it may also be
useful for commercial software and solutions in the
pharmaceutical industry.
Methodological approach
The way in which this standard fits with other existing
requirement schemes has been partly covered in ‘Meth-
ods’ - i.e. it was certainly informed by those other stan-
dards, particularly ICH GCP, but has a different focus
and level of detail. Existing validation schemes and
security audits, for instanc e ,o f t e nh a v ea ni n d u s t r y
focus (and assume industry-level resources). Detailed
examination of data management may be based on FDA
demands, that again tend to originate in industry and
have corresponding expectations. With the ECRIN
requirements list, however, we publish a set of concrete
requirements for academic clinical research centres,
within the specific perspective of European clinical trials.
In this way the new standard complements the different
existing approaches and systems. It provides an easy to
use and systematic tool for clinical trial units developing
or improving their data management system. Our stan-
dard is designed to support the validation efforts of cen-
tres by defining agreed, minimal requirements that are
GCP compliant and that are realistic for academic units.
In order to develop standards different methodological
approaches are used. Formal consensus methods, such
as Delphi method or nominal group technique offer a
structured, transparent and replicable way of synthesiz-
ing individual judgements and have been used, for
example, in the development of many guidelines. We
did not follow strictly a formal consensus development
technique but used certain features of these consensus
methods in our structured and standardised consensus
process. These features covered iterations and controlled
feedback with several rounds based on strict versioning
of documents with track changes.
Anonymous input was not used in building the con-
sensus. Instead a Working Group of experts was estab-
lished, which created strong motivation and willingness
to participate, provided a useful variety of professional
backgrounds in different disciplines, and allowed us to
make use of effective communication and collaboration
skills developed over many years. Work was based on
efficient and regular telephone conferences and face-to-
face meetings dedicated solely to the development of
the standard requirements. During the process different
opinions were expressed by the experts and minority
responses dealt with, but there were no severe dis-
agreeements or diversities of opinion on priorities within
the group. Nevertheless, there may be limitations in our
approach, which could have been overcome by a more
formal consensus technique.
Two further aspects have to be discussed. The first
aspect is related to the lack of empirical evidence avail-
able to the group in coming to a consensus about the
most suitable standard to be stipulated. This particular
standard is not alone in this - the other guidelines con-
sulted were also all essentially statements of principle,
based on ethical principles and domain expertise. The
reason for this is simply that there is no (non-anecdotal)
evidence - at least that the working party members were
aware of - that relates ‘good’ or ‘bad’ practice within
trial unit data management and IT to particular policies
or systems. This underlines the need for a concrete
operational set of standards, such as the ECRIN require-
ments, because before empirical research can be carried
out - measuring some index of overall utility, efficiency,
safety (etc.) against the practices employed by units - we
have to agree on the important aspects of practice to
assess. Most of the existing guidelines and policies are
too vague to support such a process. The ECRIN stan-
dard, however, is specific enough to potentially be useful
for this purpose.
The ECRIN standard should therefore be seen as part
of a continuously evolving set of tools, to be employed
not just in assessing or accrediting trials units, but able
to contribute to future data collection, and thus better
identification and understanding of the key aspects of
organising systems within trials units.
The fact that the requirements developed, whatever
their ultimate source, were filtered through the opinions
and expertise of group members, is related to the sec-
ond aspect - the size of the working group. Though the
25 members of the group could claim considerable
experience and expertise between them, they obviously
did not cover all types of trials units and all the possible
variations in practice.
The working group was very aware of this and was
therefore keen to disseminate the standard widely - the
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saged that once available publicly the standard will be
the subject of further discussion and will evolve further
within a wider framework, In particular the group is
anxious to engage national regulatory authorities, with a
view to exploring how the standard could be used as
widely as possible and embedded in normal practice,
rather than being seen as an additional set of require-
ments only linked to ECRIN activities.
Certification
The assembled standard requirements list will be the
basis for the planned certification of ECRIN data cen-
tres, with a certified centre expected to meet all of the
minimal requirements. Best practice standards are not
mandatory but have been included to provide guidance
to data centres who want to improve their data man-
agement practices. Certification as an ECRIN approved
data centre will demonstrate, first, compliance of the
certified centre with regulations and standards, includ-
ing GCP, second compliance with recommendations of
ECRIN in terms of data management, third, that the
centre is staffed by expert personnel, and fourth, that
the centre is competent in the management of data for
international, multicentre clinical trials. Thus, by
implementing the certification procedure based on
requirements that are GCP-compliant, ECRIN will
guaranty a standard quality level for data management
performed by academic trial units in pan European
trials.
Conclusions
The standard provided is intended to be an open and
widely used set of requirements for GCP-compliant data
management and is mainly applicable to academic trial
centres. It is intended to be used for quality manage-
ment, validation, preparation of audits, and for training
purposes. The standard can be used by all parties inter-
ested in running a data management centre in compli-
ance with GCP and in accordance with European
regulations and guidelines. ECRIN will use the require-
m e n t sa sab a s i sf o rs e l e c t i o na n dc e r t i f i c a t i o no fi t s
ECRIN data centres.
Additional material
Additional file 1: Standard requirements for GCP compliant data
management in multinational clinical trials. Version 1 from 27 May
2010 developed by the European Clinical Research Infrastructures
Network (ECRIN) Working Group on Data Centres.
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